CSIMarket
 


Elanco Animal Health Inc  (ELAN)
Other Ticker:  
 
 

ELAN's Free Cash Flow Growth by Quarter and Year

Elanco Animal Health Inc's Free Cash Flow results by quarter and year




ELAN Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 157.00 13.00 223.00 -111.70
III Quarter September 198.00 189.00 89.00 159.30
II Quarter June 61.00 312.00 149.00 4.30
I Quarter March -145.00 -62.00 22.00 126.30
FY   271.00 452.00 483.00 178.20



ELAN Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Elanco Animal Health Inc achieved in the fourth quarter 2023, above Company average Free Cash Flow surge of 1107.69% year on year, to $ 157.00 millions.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 29 other companies have achieved higher Free Cash Flow growth. While Elanco Animal Health Inc' s Free Cash Flow doubling of 1107.69% ranks overall at the positon no. 1450 in the fourth quarter 2023.




ELAN Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 1107.69 % -94.17 % - -
III Quarter September 4.76 % 112.36 % -44.13 % -
II Quarter June -80.45 % 109.4 % 3365.12 % -23.21 %
I Quarter March - - -82.58 % -
FY   -40.04 % -6.42 % 171.04 % 82.21 %

Financial Statements
Elanco Animal Health Inc's fourth quarter 2023 Free Cash Flow $ 157.00 millions ELAN's Income Statement
Elanco Animal Health Inc's fourth quarter 2022 Free Cash Flow $ 13.00 millions Quarterly ELAN's Income Statement
New: More ELAN's historic Free Cash Flow Growth >>


ELAN Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -20.71 % -93.12 % 150.56 % -
III Quarter September 224.59 % -39.42 % -40.27 % 3604.65 %
II Quarter June - - 577.27 % -96.6 %
I Quarter March - - - 29.14 %
FY (Year on Year)   -40.04 % -6.42 % 171.04 % 82.21 %




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #107
Overall #1450

Free Cash Flow Y/Y Growth Statistics
High Average Low
139.2 % 13.4 % -85.2 %
(Sep 30 2022)   (Sep 30 2023)
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #107
Overall #1450
Free Cash Flow Y/Y Growth Statistics
High Average Low
139.2 % 13.4 % -85.2 %
(Sep 30 2022)   (Sep 30 2023)

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Elanco Animal Health Inc's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
3604.65 % 429.61 % -96.6 %
(Jun 30 2020)  


ELAN's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2023 Elanco Animal Health Inc disclosed fall in Free Cash Flow from the previous quarter by -20.71% to $ 157.00 millions, from $ 198.00 millions released in the previous quarter.

It's not huge issue, as Free Cash Flow always seem to plunge in the IV. Quarter.

Within Major Pharmaceutical Preparations industry 22 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Elanco Animal Health Inc's Free Cash Flow growth quarter on quarter, overall rank is 1091.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #23
Healthcare Sector #93
Overall #1091
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #23
Healthcare Sector #93
Overall #1091
Free Cash Flow Q/Q Growth Statistics
High Average Low
3604.65 % 429.61 % -96.6 %
(Jun 30 2020)  


ELAN's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2023 Elanco Animal Health Inc disclosed fall in Free Cash Flow sequentially by -20.71% to $ 157.00 millions, from $ 198.00 millions declared in the previous quarter.

But that's not big issue, as IV. Quarter Free Cash Flow frequently gravitate to dip in the IV. Quarter.

Within Major Pharmaceutical Preparations industry 22 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Elanco Animal Health Inc's Free Cash Flow growth quarter on quarter, overall rank is 1091.


Elanco Animal Health Inc's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ 271.00 $ 127.00 $ 118.00 $ 565.00 $ 636.00
Y / Y Free Cash Flow Growth (TTM) -57.39 % -85.2 % -83.99 % -0.18 % -6.47 %
Year on Year Free Cash Flow Growth Overall Ranking # 1216 # 278 # 380 # 400 # 457
Seqeuential Free Cash Flow Change (TTM) 113.39 % 7.63 % -79.12 % -11.16 % -25.87 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 1450 # 930 # 672 # 1607 # 275




Cumulative Free Cash Flow growth Comment
Elanco Animal Health Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Elanco Animal Health Inc's annual Free Cash Flow drop would be -57.39% year on year to $271 millions.

In the Healthcare sector 91 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 278 to 1216.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
139.2 %
13.4 %
-85.2 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 92
Overall # 1216

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
139.2 %
13.4 %
-85.2 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 107
S&P 500 # 1450
Cumulative Free Cash Flow growth Comment
Elanco Animal Health Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Elanco Animal Health Inc's annual Free Cash Flow drop would be -57.39% year on year to $271 millions.

In the Healthcare sector 91 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 278 to 1216.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
139.2 %
13.4 %
-85.2 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 92
Overall # 1216

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
139.2 %
13.4 %
-85.2 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 107
S&P 500 # 1450




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ELAN's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ELAN's Competitors
Free Cash Flow Growth for Elanco Animal Health Inc's Suppliers
Free Cash Flow Growth for ELAN's Customers

You may also want to know
ELAN's Annual Growth Rates ELAN's Profitability Ratios ELAN's Asset Turnover Ratio ELAN's Dividend Growth
ELAN's Roe ELAN's Valuation Ratios ELAN's Financial Strength Ratios ELAN's Dividend Payout Ratio
ELAN's Roa ELAN's Inventory Turnover Ratio ELAN's Growth Rates ELAN's Dividend Comparisons



Companies with similar Free Cash Flow drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Select Medical Holdings Corp1,330.50%$ 1,330.501 millions
Elanco Animal Health Inc1,107.69%$ 1,107.692 millions
Surgery Partners Inc 769.44%$ 769.444 millions
Anika Therapeutics Inc 656.34%$ 656.341 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com